Europe Genotyping Market Size & Outlook, 2023-2030

The genotyping market in Europe is expected to reach a projected revenue of US$ 13,394.7 million by 2030. A compound annual growth rate of 14.2% is expected of Europe genotyping market from 2024 to 2030.
Revenue, 2023 (US$M)
$5,277.5
Forecast, 2030 (US$M)
$13,394.7
CAGR, 2024 - 2030
14.2%
Report Coverage
Europe

Europe genotyping market highlights

  • The Europe genotyping market generated a revenue of USD 5,277.5 million in 2023.
  • The market is expected to grow at a CAGR of 14.2% from 2024 to 2030.
  • In terms of segment, reagents & kits was the largest revenue generating product in 2023.
  • Reagents & kits is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 5,277.5 million
Market revenue in 2030USD 13,394.7 million
Growth rate14.2% (CAGR from 2023 to 2030)
Largest segmentReagents & kits
Fastest growing segmentReagents & kits
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents & kits, Services
Key market players worldwideIllumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 29.4% of the global genotyping market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 12,067.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Genotyping Market Companies

Name Profile # Employees HQ Website

Europe genotyping market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.


Reagents & kits was the largest segment with a revenue share of 61.15% in 2023. Horizon Databook has segmented the Europe genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.


Growing prevalence of cardiovascular disorders and genetic disorders coupled with increasing investments in genotyping research is expected to contribute to market growth. However, the current European economic crisis and presence of uneven reimbursement policies may restrain market growth.

In 2017, a new regulation was issued regarding IVD & medical devices in European countries, which is likely to be updated by 2022. The new regulation is expected to offer a more sustainable and robust framework for compliance of genotyping and diagnostic devices.

Furthermore, introduction of novel products and increasing importance of SNP genotyping in drug development are among major factors responsible for market growth. Increasing government funding, genetic counseling program by government, and growing investments in healthcare sector are some of the high-impact rendering drivers in Europe.

Reasons to subscribe to Europe genotyping market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe genotyping market databook

  • Our clientele includes a mix of genotyping market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe genotyping market , including forecasts for subscribers. This continent databook contains high-level insights into Europe genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe genotyping market size, by country, 2018-2030 (US$M)

Europe Genotyping Market Outlook Share, 2023 & 2030 (US$M)

Europe genotyping market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more